The polypill and cardiovascular disease - May be appropriate for secondary, but perhaps notfor primary prevention

被引：15

作者：

Fahey, T ^{[1
]}

Brindle, P

Ebrahim, S

机构：

[1] Univ Dundee, Tayside Ctr Gen Practice, Dundee DD2 4AD, Scotland

[2] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7499期

关键词：

D O I：

10.1136/bmj.330.7499.1035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1035 / 1036

页数：2

共 13 条

[1] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].

Clarke, R ;

Collins, R ;

Lewington, S ;

Donald, A ;

Alfthan, G ;

Tuomilehto, J ;

Arnesen, E ;

Bonaa, K ;

Blacher, J ;

Boers, GHJ ;

Bostom, A ;

Bots, ML ;

Grobee, DE ;

Brattström, L ;

Breteler, MMB ;

Hofman, A ;

Chambers, JC ;

Kooner, JS ;

Coull, BM ;

Evans, RW ;

Kuller, LH ;

Evers, S ;

Folsom, AR ;

Freyburger, G ;

Parrot, F ;

Genst, J ;

Dalery, K ;

Graham, IM ;

Daly, L ;

Hoogeveen, EK ;

Kostense, PJ ;

Stehouwer, CDA ;

Hopknis, PN ;

Jacques, P ;

Selhub, J ;

Luft, FC ;

Jungers, P ;

Lindgren, A ;

Lolin, YI ;

Loehrer, F ;

Fowler, B ;

Mansoor, MA ;

Malinow, MR ;

Ducimetiere, P ;

Nygard, O ;

Refsum, H ;

Vollset, SE ;

Ueland, PM ;

Omenn, GS ;

Beresford, SAA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022

[2]

Eidelman R, 2005, ARCH INTERN MED, V163, P2006

[3] Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism:: prospective and case-control studies from the Copenhagen City Heart Study [J].

Frederiksen, J ;

Juul, K ;

Grande, P ;

Jensen, GB ;

Schroeder, TV ;

Tybjærg-Hansen, A ;

Nordestgaard, BG .

BLOOD, 2004, 104 (10) :3046-3051

[4] Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses [J].

Hennekens, CH ;

Sacks, FM ;

Tonkin, A ;

Jukema, JW ;

Byington, RP ;

Pitt, B ;

Berry, DA ;

Berry, SM ;

Ford, NF ;

Walker, AJ ;

Natarajan, K ;

Sheng-Lin, C ;

Fiedorek, FT ;

Belder, R .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) :40-44

[5] Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis [J].

Hippisley-Cox, J ;

Coupland, C .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7499) :1059-1063

[6] Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? [J].

Lawlor, DA ;

Smith, GD ;

Bruckdorfer, KR ;

Kundu, D ;

Ebrahim, S .

LANCET, 2004, 363 (9422) :1724-1727

[7] The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis [J].

Montgomery, AA ;

Fahey, T ;

Ben-Shlomo, Y ;

Harding, J .

JOURNAL OF HYPERTENSION, 2003, 21 (09) :1753-1759

[8] The middle-aged and older American: Wrong prototype for a preventive polypill? [J].

Mulrow, C ;

Kussmaul, W .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) :467-468

[9] A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women [J].

Ridker, PM ;

Cook, NR ;

Lee, IM ;

Gordon, D ;

Gaziano, JM ;

Manson, JE ;

Hennekens, CH ;

Buring, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1293-1304

[10] Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial [J].

Toole, JF ;

Malinow, MR ;

Chambless, LE ;

Spence, JD ;

Pettigrew, LC ;

Howard, VJ ;

Sides, EG ;

Wang, CH ;

Stampfer, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :565-575

← 1 2 →